Medical Devices Investors & VC Firms in Asia-Pacific

178 firms in this list, with a median first check of $1M. 28 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
AP Apex Innovative Investments Ventures MHADASSC9 people	88🔒	Vancouver	CA	Pre-Seed–Series A	$250K	+ Add to CRM
IN Industrial Technology Investment Corporation	88🔒	Taipei	TW	Seed–Late Stage	$1.9M – $227M	+ Add to CRM
MI Miyako Capital 三宏山哲菅常川英5 people	88🔒	Kyoto	JP	Pre-Seed–Growth	—	+ Add to CRM
EL Elev8.vc CKEAHTAM7 people	88🔒	Singapore	SG	Pre-Seed–Series A	$5M – $15M	+ Add to CRM
OV Overwater Ventures Llc KSIRAAAM7 people · Leads rounds	88🔒	Palo Alto	US	Pre-Seed–Series A	$400K – $2M	+ Add to CRM
KU Kumpulan Modal Perdana YYLHHHLS12 people	88🔒	Petaling Jaya	MY	Seed–Late Stage	$380K – $1.5M	+ Add to CRM
NS NSG Ventures DTJLTLKN9 people	88🔒	Singapore	SG	Seed–Series A	—	+ Add to CRM
SY Sycamore Ventures KTPGDHKY13 people	88🔒	Princeton	US	Growth–Late Stage	$5M – $20M	+ Add to CRM
LA Laerdal Million Lives Fund JTBSDSJJ9 people	88🔒	San Francisco	US	Series A–Series B	$1M – $5M	+ Add to CRM
DE Detong Capital JTRSSJTL11 people	88🔒	Shanghai	CN	Seed–Late Stage	$20M	+ Add to CRM
AS Asia2G Capital AJAKIHJJ5 people	88🔒	Silicon Valley	US	Pre-Seed–Series A	—	+ Add to CRM
IN Innvotec Ltd. MTNDSPST4 people	88🔒	London	GB	Series A–Series B	$317.5K – $635K	+ Add to CRM
MI MIRAI SOUZOU	88🔒	Tokyo	JP	Pre-Seed–Growth	—	+ Add to CRM
IN InHealth Ventures IBBELBRB5 people · Leads rounds	88🔒	London	GB	Pre-Seed–Series A	$500K – $3M	+ Add to CRM
KO Korea Investment Partners DJJHJHMS17 people	88🔒	Seoul	KR	Seed–Late Stage	$973K – $50M	+ Add to CRM
PI Pivotal Life Sciences GBAVBMJL13 people	88🔒	San Francisco	US	Seed–Late Stage	—	+ Add to CRM
BP BPEA EQT JETHHGAA8 people · Leads rounds	88🔒	—	SG	Series B–Late Stage	$50M – $3B	+ Add to CRM
KA Kama Flow EBKT2 people	88🔒	Moscow	RU	Seed–Late Stage	—	+ Add to CRM
AR Artem Ventures LZNSTOFX6 people	88🔒	Selangor	MY	Pre-Seed–Series A	$34K – $2.3M	+ Add to CRM
BO Boson Ventures ACDXHLHC9 people · Leads rounds	88🔒	Melbourne	AU	Pre-Seed–Series A	—	+ Add to CRM
ID IDG Capital JNMLQZXL5 people	88🔒	Hong Kong	HK	Pre-Seed–Late Stage	$3M – $200M	+ Add to CRM
PA Pappas Capital APEKSWTM7 people	88🔒	Research Triangle Park	US	Seed–Late Stage	$100K – $6M	+ Add to CRM
DF DFJ DragonFund	88🔒	Shanghai	CN	Seed–Late Stage	—	+ Add to CRM
IN Inclusion Japan Leads rounds	88🔒	—	JP	Pre-Seed–Growth	—	+ Add to CRM

Apex Innovative Investments Ventures

VancouverPre-Seed–Series A$250K

MHADASSC9 people

Industrial Technology Investment Corporation

TaipeiSeed–Late Stage$1.9M – $227M

Miyako Capital

KyotoPre-Seed–Growth

三宏山哲菅常川英5 people

Elev8.vc

SingaporePre-Seed–Series A$5M – $15M

CKEAHTAM7 people

Overwater Ventures Llc

Palo AltoPre-Seed–Series A$400K – $2M

KSIRAAAM7 people

Kumpulan Modal Perdana

Petaling JayaSeed–Late Stage$380K – $1.5M

YYLHHHLS12 people

NSG Ventures

SingaporeSeed–Series A

DTJLTLKN9 people

Sycamore Ventures

PrincetonGrowth–Late Stage$5M – $20M

KTPGDHKY13 people

Laerdal Million Lives Fund

San FranciscoSeries A–Series B$1M – $5M

JTBSDSJJ9 people

Detong Capital

ShanghaiSeed–Late Stage$20M

JTRSSJTL11 people

Asia2G Capital

Silicon ValleyPre-Seed–Series A

AJAKIHJJ5 people

Innvotec Ltd.

LondonSeries A–Series B$317.5K – $635K

MTNDSPST4 people

MIRAI SOUZOU

TokyoPre-Seed–Growth

InHealth Ventures

LondonPre-Seed–Series A$500K – $3M

IBBELBRB5 people

Korea Investment Partners

SeoulSeed–Late Stage$973K – $50M

DJJHJHMS17 people

Pivotal Life Sciences

San FranciscoSeed–Late Stage

GBAVBMJL13 people

BPEA EQT

Series B–Late Stage$50M – $3B

JETHHGAA8 people

Kama Flow

MoscowSeed–Late Stage

EBKT2 people

Artem Ventures

SelangorPre-Seed–Series A$34K – $2.3M

LZNSTOFX6 people

Boson Ventures

MelbournePre-Seed–Series A

ACDXHLHC9 people

IDG Capital

Hong KongPre-Seed–Late Stage$3M – $200M

JNMLQZXL5 people

Pappas Capital

Research Triangle ParkSeed–Late Stage$100K – $6M

APEKSWTM7 people

DFJ DragonFund

ShanghaiSeed–Late Stage

Inclusion Japan

Pre-Seed–Growth

Data sourced from public filings and firms' own websites — see our methodology.